Merck (MRK.N) has entered a licensing agreement worth up to $2 billion with Chinese biotech firm Hansoh Pharma (3692.HK) for the development of an experimental oral...
Etiket: Novo Nordisk
Regulatory Conditions Cleared for Novo Holdings’ $16.5 Billion Catalent Acquisition
Novo Holdings announced on Saturday that all regulatory conditions for its $16.5 billion acquisition of U.S. contract drug manufacturer Catalent have been fulfilled. The companies anticipate...
Novo Nordisk India Pushes for Early Wegovy Launch Amid Rising Competition
Novo Nordisk’s Indian team is urging the Danish pharmaceutical company to expedite the launch of its weight-loss drug Wegovy to counter Eli Lilly’s upcoming rival product,...